2023 - The Benefits of Digital Pathology with Automated Quality Control for Accelerating Drug Discovery
Date2023-02-15
Deadline2023-02-15
VenueWebinar, USA - United States
KeywordsQuality Control; Drug Discovery; Pathology
Topics/Call fo Papers
Digital pathology and computational pathology have become an integral part of the drug discovery and development process and are playing an increasingly important role in R&D and diagnostic labs. These computational pathology solutions use artificial intelligence (AI) to increase the efficiency of lab operations, help organizations drive new breakthroughs and improve diagnostic precision. As digital and computation pathology adoption increases and labs look to optimize their workflows in a digital environment, there are opportunities for computational technology to not only improve the way that images are analyzed but improve on — or even eliminate — many of the manual and routine processes and tasks throughout the pathology workflow.
For example, the process of ensuring slide and image quality is time consuming for laboratory technicians and pathologists to review and ensure that images are of sufficient quality prior to analysis. Quality challenges are costly and disruptive, particularly if a rescan is initiated by a scientist or pathologist whose valuable time is being diverted away from analysis to address quality issues. Additionally, artifacts affecting slides may affect the accuracy of diagnosis and research. It is more cost effective and workflow efficient to catch these poor quality images as soon as possible. This webinar explores such technological advances in improving slide and image quality along with the benefits of digital pathology with Automated Quality Control for accelerating drug discovery.
Join this webinar to learn the benefits of digital pathology with automated quality control for accelerating drug discovery.
For example, the process of ensuring slide and image quality is time consuming for laboratory technicians and pathologists to review and ensure that images are of sufficient quality prior to analysis. Quality challenges are costly and disruptive, particularly if a rescan is initiated by a scientist or pathologist whose valuable time is being diverted away from analysis to address quality issues. Additionally, artifacts affecting slides may affect the accuracy of diagnosis and research. It is more cost effective and workflow efficient to catch these poor quality images as soon as possible. This webinar explores such technological advances in improving slide and image quality along with the benefits of digital pathology with Automated Quality Control for accelerating drug discovery.
Join this webinar to learn the benefits of digital pathology with automated quality control for accelerating drug discovery.
Other CFPs
- Breaking Down Barriers in Support of Patients with Rare Diseases
- ECom Design Summit Online
- 3rd International Conference on Research in Social Science, Economics and Business Sustainability (RSEB-AUGUST-2023)
- 3rd International Conference on Emerging Innovations in Business Research & Social Sciences (EBRS-JULY-2023)
- ISER 2nd International Conference on Innovative Research in Economics, Innovation Managements, Social Science & Humanities
Last modified: 2023-01-17 04:09:00